This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Letters to the Editor -
45,XY,der(13;14)(q10;q10) in an azoospermic man with hypogonadotrophic hypogonadism
Ozge Ozalp1, Zerrin
Yilmaz1, Esra Bulgan
Kilicdag2, Filiz Bolat3, Tayfun
Bagis2, Feride Iffet Sahin1
1Department of Medical Genetics,
2Department of Obstetrics and Gynecology,
3Department of Pathology, Baskent University Faculty of Medicine, Adana 06570, Turkey
Correspondence to: Assoc. Prof. Dr. Feride Iffet Sahin, Baskent University Faculty of Medicine, Department of
Medical Genetics, Kubilay Sokak No. 36 Maltepe, Ankara 06570, Turkey.
Tel: +90-312-232-4400 ext. 138, Fax: +90-312-232-3912; E-mail: feridesahin@hotmail.com
Received 2005-11-25 Accepted 2006-02-17
DOI: 10.1111/j.1745-7262.2006.00193.x
Dear Sir,
I am Feride Iffet Sahin in Baskent University Faculty of Medicine, Department of Medical Genetics, Ankara,
Turkey. We write to you about a case of 45,XY,der(13;14)(q10;q10) in an azoospermic man as a result of
hypo-gonadotrophic hypogonadism.
The most frequent form of Robertsonian translocation is between chromosomes 13 and 14 [1]. It is reported to
be a cause of male infertility [2_4]. The frequency of Robertsonian translocation among infertile men has been
reported to be 1%, which is higher than that of the normal newborn population [2, 5]. The translocated chromosomes
cause inappropriate pairing during male meiosis and hinder normal sperm production, resulting in oligo- and azoospermia.
A 34-year-old male patient was referred to
the Department of Medical Genetics from the Department of Obstetrics
and Gynecology, Baskent University Faculty of Medicine, for chromosome analysis and Y microdeletion testing because
of azoospermia as a result of hypogona-dotropic hypogonadism.
During genetic counseling, we learned that the patient was one of the seven children of a nonconsanguineous married
couple. The patient's mother had no miscarriages in her obstetric history. All his married siblings (three sisters and
three brothers) had healthy children. His two elder sisters each had two spontaneous abortions in their obstetric
history. There were no other significant findings in his family history. Cytogenetic and Y-deletion screening tests
were performed after informed consent was obtained from the patient.
The diagnosis of hypogonadotrophic hypogonadism was made in the Endocrinology Department of our university
by low luteinizing hormone (LH), follicle-stimulating hormone (FSH) and total testosterone levels 4 years ago. The
baseline serum concentrations of thyroid-stimulating hormone (1.32 µIU/L, normal range [n.r.]: 0.3_ 4.0 µIU/L) and
prolactin (211.64 mIU/L, n.r.: 25.20_ 628.53 mIU/L), were normal, but those of FSH, LH and total testosterone
were very low in serum samples collected on different occasions (0.19_0.44 mIU/mL, n.r.: 1_15 mIU/mL;
0.07_0.08 mIU/mL, n.r.: 2_10 mIU/L; and 1.70 ng/mL, n.r.: 2.88_8.88 ng/mL, respectively). Blood samples were obtained
0, 25, 75 and 90 min after stimulation with 100 mg intravenous GnRH-a (Leuprolide acetate; Lucrin, Abbott, France)
for examination of FSH, LH and total testosterone levels. Extremely low non-pulsatile FSH (1.24, 1.33 and
1.40 mIU/L, respectively) and LH levels (0, 0.22 and 0.12 mIU/L, respectively) were obtained after 0, 25 and 75 min,
whereas a rise in total testosterone levels was detected (0.2, 3.57 and
4.11 ng/mL at 0, 75 and 90 min, respectively). It is likely
that the pituitary insufficiently prevented the normal rise in serum FSH and LH levels. Inhibin B levels were not
obtained because of the condition of our laboratory.
There was no history of episode of anosmia, head injury or granulomatous diseases, such as tuberculosis or
excessive exercise. No causative abnormalities were detected in imaging studies, including magnetic resonance
imaging of hypophysis and computed tomography of the head. The patient was not married at the time of the present
study, and complained of sexual infantilism. His penis was measured at 6 cm and testicles were recorded to be small.
Azoospermia was detected in spermiogram. After the diagnosis, he was treated with testosterone and human
chorionic gonadotrophin (HCG) preparations for 6 months. Total testosterone levels elevated after this period (7 ng/mL)
but azoospermia persisted despite normal testosterone levels. After 6-month treatment, testosterone treatment
discontinued and HCG was administered for additional 6 months. After this treatment period, testosterone level was still in
the normal range (total testosterone [6.51 ng/mL, n.r.: 2.88_8.88], free testosterone
[20 pg/mL, n.r.: 6.2_28.1], FSH [1 mIU/L] and LH [< 0.07 mIU/L] levels remained low and spermiogram revealed 1_2 immotile spermatozoa).
Treatment protocol was shifted to Follitropin alpha 150 IU and HCG 1500 IU every other day and the patient was followed
for additional 2 years. Although testosterone remained normal, we could not detect any changes in the spermiogram.
He was married during the 2-year follow-up and consulted Assisted Reproduction Unit, Department of Obstetrics and
Gynecology, for further investigation because of infertility. In the scrotal ultrasonography
(USG), bilateral testicular atrophy and varicocoele of the left testis was detected. The spermiogram was reported as azoospermia once more
and testis biopsy was performed.
Following the tissue processing, biopsies were embedded in paraffin blocks. Four-µm-thick sections from each
specimen were taken and stained with hematoxylin and eosin (HE). Microscopic evaluation of HE stained sections
revealed thickening in basement membranes of seminiferous tubuli. Most of the tubuli were composed only of sertoli
cells. Few tubuli contained germ cells showing maturation up to the spermatide I_II level. The diagnosis was
incomplete maturation arrest.
Chromosome analysis was made from peripheral blood lymphocyte cultures according to standart protocols and
Trypsin-Giemsa banding (GTG) at the 450_500 band level was performed. Karyotype analysis was made in 30
metaphase spreads resulting in 45,XY,der(13;14)(q10;q10) (Figure 1) [6].
Genomic DNA was isolated from peripheral blood samples by DNA isolation kit (Roche Diagnostics, Code: 1 796
828, Mannheim, Germany). Microdeletion analysis was carried out using two primers (sY 84 and sY 86) for AZFa,
three primers (sY 131, sY 143 and sY 164) for AZFb and five primers (sY 152, sY 254, sY 255, sY 277 and sY 283)
for AZFc regions, and polymerase chain reaction (PCR) products were analyzed by running in 2% agarose gels. No
deletions were detected.
In the current case, our patient had a Robertsonian translocation involving chromosomes 13 and 14. In the
Robertsonian translocations, prophase I of meiosis results in a trivalent structure because of the rearrangement of the
chromosomes, and results in alternate segregation. Changed segregation patterns might result in balanced or
unbalanced gametes and offspring. Unbalanced offspring are usually lost by spontaneous abortions [7].
Male infertility is associated with structural chromosome abnormalities
[3]. Meiotic behavior of translocation chromosomes results in different degrees of meiotic arrest and oligozoospermia or azoospermia are found in these
patients [4]. Luciani et al. [8] investigated the mechanism of segregation in meiosis in a der(13q;14q) carrier. They
tried to elucidate the reason for spermatogenesis arrest in men.
Sex vesicle formation occurs in male pachytene and X and Y chromosomes together are responsible for the structure.
No sex vesicle is formed during female meiosis [9]. In XXY males, no sex vesicle formation is observed in cells with an
XX bivalent and X-chromosome inactivation cannot occur, which leads to meiotic arrest [3].
In der(13q;14q) patients, a trivalent configuration occurs in meiosis between the normal and translocation
chromosomes. They completely pair from band p11 to the distal long arm. The normal and translocated
chromosomes differ in a lightly stained region distal to the short arm. With silver staining methods, the region was heavily
stained in normal chromosomes, indicating the nucleolar
organizing region (NOR). In translocation chromosomes,
the NOR region was not stained. This trivalent interacts with the sex vesicle through the X chromosome, not the Y
chromosome [8]. The interacting region is the centromere of the translocation chromosome. The normal
chromosomes joining the trivalent structure associate with other acrocentric bivalent chromosomes through their NOR
regions [8].
During spermatogenesis, both the X and Y chromosomes undergo transient inactivation through epigenetic
mechanisms such as histone modifications [10, 11]. The interaction of the translocation chromosome with the X
chromosome in the sex vesicle interferes with X chromosome inactivation [8]. This interaction has been reported in a male
with a balanced translocation [8]. Interference of X inactivation interacts with the gametogenesis in male patients by
disturbing the orderly functions of biochemical machinery and results in oligozoospermia or azoospermia.
Luciani et al. [8] reported the interaction rate of the translocation chromosome with the sex vesicle as 61% in their
study. The rest of the meioses do not involve the interaction of the translocation chromosome with the sex vesicle.
This probably explains why not all der(13q;14q) carriers are azoospermic. In our patient, the reason for azoospermia
is probably the high percentage of this interaction.
To our knowledge, this is the first report of azoospermia secondary to chromosomal defect of der(13q;14q)
complicated by a pituitary problem. We conclude that relevant physicians have to take into account other causes of
azoospermia when evaluating hormone treatment failure in azoospermia as a result of hypogonado-tropic hypogonadism.
We informed the patient and offered preimplantation genetic diagnosis (PGD), because we believe that sperm
fluorescence in situ hybridization analysis will be unbeneficial. During the genetic counseling the patient wanted to try
at least one cycle of in vitro fertilization (IVF) and is taking medication 150 IU follitropin alpha every other day and
250 mg choriogonadotropin alpha every other day. If IVF succeeds, PGD will be performed on blastomere biopsies.
References
1 Therman E, Susman B, Denniston C. The nonrandom participation of human acrocentric chromosomes in Robertsonian translocations.
Ann Hum Genet 1989; 53: 49_65.
2 Tuerlings JH, de France HF, Hamers A, Hordijk R, Van Hemel JO, Hansson K,
et al. Chromosome studies in 1792 males prior to
intra-cytoplasmic sperm injection: the Dutch experience. Eur J Hum Genet 1998; 6: 194_200.
3 Egozcue S, Blanco J, Vendrell JM, Garcia F, Veiga A, Aran B,
et al. Human male infertility: chromosome anomalies, meiotic disorders,
abnormal spermatozoa and recurrent abortion. Hum Reprod Update 2000; 6: 93_105.
4 Morel F, Roux C, Bresson JL. FISH analysis of the chromosomal status of spermatozoa from three men with 45,XY,der(13;14)(q10;q10)
karyotype. Mol Hum Reprod 2001; 7: 483_8.
5 Escudero T, Lee M, Carrel D, Blanco J, Munne S. Analysis of chromosome abnormalities in sperm and embryos from two
45,XY,t(13;14)(q10;q10) carriers. Prenat Diagn 2000; 20: 599_602.
6 Mitelman F. ISCN (An International System for Human Cytogenetic Nomenclature)1995. Basel: S Karger, 1995.
7 Shah K, Sivapalan G, Gibbons N, Tempest H, Griffin DK. The genetic basis of infertility. Reproduction 2003; 126: 13_25.
8 Luciani JM, Guichaoua MR, Mattei A, Morazzani MR. Pachytene analysis of a man with a 13q;14q translocation and infertility. Behavior
of the trivalent and nonrandom association with the sex vesicle.Cytogenet Cell Genet 1984; 38: 14_22.
9 Vidal F, Navarro J, Templado C, Brusadin S, Egozcue J. Synaptonemal complex studies in a mosaic 46,XY/47,XXY male. Hum Genet
1984; 66: 306_8.
10 Migeon BR. X-chromosome inactivation: molecular mechanisms and genetic consequences. Trends Genet 1994; 10: 230_5.
11 Khalil AM, Boyar FZ, Driscoll DJ. Dynamic histone modifications mark sex chromosome inactivation and reactivation during
mammalian spermatogenesis. Proc Natl Acad Sci USA 2004; 101: 16583_7.
|